Showing results (131-140 of 160) with videos related to

Sort By:
Pageof 16
In Vivo (Athens, Greece)|April 28, 2019
Comparison of PANAMutyper and PNAClamp for Detecting KRAS Mutations from Patients With Malignant Pleural EffusionSu Yeon Choi, Hyung Woo Kim, Sang Hoon Jeon, et al.
In Vivo (Athens, Greece)|February 27, 2019
Comparison of PNA Clamping-assisted Fluorescence Melting Curve Analysis and PNA Clamping in Detecting <i>EGFR</i> Mutations in Matched Tumor Tissue, Cell Block, Pleural Effusion and Blood of Lung Cancer Patients With Malignant Pleural EffusionSang Hoon Jeon, Hyung Woo Kim, Bit Na Kim, et al.
Annals of Surgical Oncology|May 14, 2015
Bis Expression in Patients with Surgically Resected Lung Cancer and its Clinical SignificanceChang Dong Yeo, Gyeong Sin Park, Nahyeon Kang, et al.
Tuberculosis and Respiratory Diseases|June 22, 2018
Clinical Characteristics of False-Positive Lymph Node on Chest CT or PET-CT Confirmed by Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration in Lung CancerJongmin Lee, Young Kyoon Kim, Ye Young Seo, et al.
Lung Cancer (Amsterdam, Netherlands)|June 24, 2015
Silencing of miR-137 by aberrant promoter hypermethylation in surgically resected lung cancerNahyeon Kang, Su Yeon Choi, Young Kyoon Kim, et al.
BMC Urology|March 22, 2017
miRNAs associated with prostate cancer risk and progressionHung N Luu, Hui-Yi Lin, Karina Dalsgaard Sørensen, et al.
Biomolecules|January 21, 2022
Dysregulation of DNA Methylation and Epigenetic Clocks in Prostate Cancer among Puerto Rican MenAnders Berglund, Jaime Matta, Jarline Encarnación-Medina, et al.
The Clinical Respiratory Journal|January 5, 2025
Study Protocol of the Korean EGFR Registry: A Multicenter Prospective and Retrospective Cohort Study in Nonsmall Cell Lung Cancer Patients With EGFR MutationChang Dong Yeo, Dong Won Park, Seong Hoon Yoon, et al.
Anticancer Research|February 27, 2022
First-line Afatinib in Patients With Non-small-cell Lung Cancer With Uncommon EGFR Mutations in South KoreaMi-Hyun Kim, Chang Min Choi, Sung Yong Lee, et al.
Lung Cancer (Amsterdam, Netherlands)|September 14, 2010
A multicenter phase II study of belotecan, a new camptothecin analogue, as a second-line therapy in patients with small cell lung cancerChin Kook Rhee, Sang Haak Lee, Ju Sang Kim, et al.
Pageof 16